Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Brentuximab Vedotin i chemioterapia skojarzona w leczeniu dzieci i młodzieży z chłoniakiem Hodgkina w stadium IIB, IIIB, IVA lub IVB

10 listopada 2026 zaktualizowane przez: National Cancer Institute (NCI)

Randomizowane badanie III fazy dotyczące stosowania brentuksymabu vedotin (SGN-35) w przypadku nowo rozpoznanego klasycznego chłoniaka Hodgkina (cHL) wysokiego ryzyka u dzieci i młodych dorosłych

This phase III trial studies brentuximab vedotin and combination chemotherapy to see how well they work compared to combination chemotherapy alone in treating children and young adults with stage IIB with bulk, stage IIIB, IVA, or IVB Hodgkin lymphoma. Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Chemotherapy drugs, such as doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known if combination chemotherapy is more effective with or without brentuximab vedotin in treating children with high-risk Hodgkin lymphoma.

Przegląd badań

Status

Aktywny, nie rekrutujący

Warunki

Interwencja / Leczenie

Szczegółowy opis

PRIMARY OBJECTIVE:

I. To assess the event free survival (EFS) of a novel regimen incorporating brentuximab vedotin (Bv; Adcetris) in the chemotherapy backbone of doxorubicin hydrochloride (doxorubicin) (Adriamycin), vincristine sulfate (vincristine), etoposide, prednisone and cyclophosphamide (Bv-AVEPC) in newly diagnosed high-risk classical Hodgkin lymphoma (cHL) compared to those treated with Adriamycin, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide (ABVE-PC).

SECONDARY OBJECTIVES:

I. To determine whether children/young adults with high-risk cHL treated with Bv-AVEPC have a higher rate of early response (determined by fludeoxyglucose F 18 [FDG]-positron emission tomography [PET]) and a reduction in protocol directed radiation therapy (RT) compared to those treated with ABVE-PC.

II. To compare the rate of neuropathy (>= grade 3) among patients treated on the Bv-AVEPC (experimental arm) to patients treated on the ABVE-PC (standard arm).

EXPLORATORY OBJECTIVES:

I. To validate and compare the Childhood Hodgkin International Prognostic Score (CHIPS) to conventional Ann Arbor stage (stages II B with bulk, III B, IV A or B) in predicting outcome in high-risk childhood cHL.

II. To determine the incidence of preferentially expressed antigen in melanoma (PRAME) and testis-specific antigens in Epstein-Barr virus (EBV)- cHL tumors and the incidence of EBV antigens (Epstein-Barr nuclear antigen 1 [EBNA1], Epstein-Barr virus latent membrane protein 1 [LMP1], large multifunctional peptidase 2 [LMP2]) in EBV+ cHL tumors, with the goal of developing strategies to integrate cellular therapy into treatment for newly diagnosed high-risk cHL. (Biology) III. To incorporate qualitative visual FDG-PET into response-directed treatment algorithms and explore quantitative FDG-PET and computed tomography (CT) definitions of tumor burden and response for incorporation into next generation pediatric cHL risk-stratification schemes, exploring the extension of these algorithms to young adults. (Imaging) IV. To evaluate the reduction in normal tissue irradiation associated with the current treatment approach compared to the volume of historic involved field radiation therapy (IFRT) fields. (Radiation Therapy) V. To evaluate EFS and patterns of relapse following protocol-specified RT utilization and treatment volumes. (Radiation Therapy) VI. To characterize the extent of chemotherapy induced peripheral neuropathy (CIPN), as reported by patients and parent proxies, through serial administration of the Functional Assessment of Cancer Therapy-Gynecologic Oncology Group-Neurotoxicity (FACT-GOG-NTX). (Patient Reported Outcomes [PRO] of Peripheral Neuropathy and Health-Related Quality of Life) VII. To describe the Health-Related Quality of Life (HRQL) consequences of peripheral neuropathy over time by correlating total neuropathy scale scores with the individual items with the Child Health Ratings Inventories (CHRIs)-Global scale (e.g., physical health, pain, emotional functioning). (PRO of Peripheral Neuropathy and Health-Related Quality of Life) VIII. To perform a cross validation of the FACT-GOG-NTX with the Total Neuropathy Score-Pediatric Vincristine (TNS-PV) to determine the performance of both measures with the use of brentuximab vedotin in a limited institutional approach in children and adolescents with cHL. (PRO of Peripheral Neuropathy and Health-Related Quality of Life) IX. To assess the resource use and cost implications of Bv in combination with chemotherapy and radiotherapy (RT) for newly diagnosed high-risk cHL in children and young adults. (Economic) X. To estimate the risk of relapse among rapidly responding lesions (RRL) subjects that have at least one lesion that is Deauville 3 at PET 2. (Follow-up of Deauville score 3 lesions on FDG-PET imaging [confirmed by central imaging review]) XI. To characterize the pharmacokinetics of brentuximab vedotin in children < 13 years of age.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I (ABVE-PC): Patients receive doxorubicin hydrochloride intravenously (IV) over on days 1-2, bleomycin sulfate IV or subcutaneously (SC) on days 1 and 8, vincristine sulfate IV on days 1 and 8, etoposide IV on days 1-3, prednisone orally (PO) twice daily (BID) or methylprednisolone IV on days 1-7, and cyclophosphamide IV on days 1 and 2.

ARM II (Bv-AVEPC): Patients receive brentuximab vedotin IV on day 1. Patients also receive doxorubicin hydrochloride, etoposide, prednisone or methylprednisolone, and cyclophosphamide as in Arm I and vincristine sulfate IV on day 8.

In both arms, treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity. Granulocyte simulating factor (GCSF) or equivalent is given on both arms.

After completion of study treatment, patients are followed up at 3, 6, 9, 12, 18, 24, 30, 36, and 48 months.

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

600

Faza

  • Faza 3

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

      • Québec, Kanada, G1V 4G2
        • CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL)
    • Alberta
      • Calgary, Alberta, Kanada, T3B 6A8
        • Alberta Children's Hospital
      • Edmonton, Alberta, Kanada, T6G 2B7
        • University of Alberta Hospital
    • British Columbia
      • Vancouver, British Columbia, Kanada, V6H 3V4
        • British Columbia Children's Hospital
    • Manitoba
      • Winnipeg, Manitoba, Kanada, R3E 0V9
        • CancerCare Manitoba
    • Nova Scotia
      • Halifax, Nova Scotia, Kanada, B3K 6R8
        • IWK Health Centre
    • Ontario
      • Hamilton, Ontario, Kanada, L8N 3Z5
        • McMaster Children's Hospital at Hamilton Health Sciences
      • Kingston, Ontario, Kanada, K7L 2V7
        • Kingston Health Sciences Centre
      • London, Ontario, Kanada, N6A 5W9
        • Children's Hospital
      • Ottawa, Ontario, Kanada, K1H 8L1
        • Children's Hospital of Eastern Ontario
      • Toronto, Ontario, Kanada, M5G 1X8
        • Hospital for Sick Children
    • Quebec
      • Montreal, Quebec, Kanada, H3H 1P3
        • The Montreal Children's Hospital of the MUHC
      • Montreal, Quebec, Kanada, H3T 1C5
        • Centre Hospitalier Universitaire Sainte-Justine
    • Saskatchewan
      • Saskatoon, Saskatchewan, Kanada, S7N 4H4
        • Saskatoon Cancer Centre
      • Caguas, Portoryko, 00726
        • HIMA San Pablo Oncologic Hospital
      • San Juan, Portoryko, 00926
        • University Pediatric Hospital
      • San Juan, Portoryko, 00912
        • San Jorge Children's Hospital
    • Alabama
      • Birmingham, Alabama, Stany Zjednoczone, 35233
        • Children's Hospital of Alabama
      • Mobile, Alabama, Stany Zjednoczone, 36604
        • USA Health Strada Patient Care Center
    • Alaska
      • Anchorage, Alaska, Stany Zjednoczone, 99508
        • Providence Alaska Medical Center
    • Arizona
      • Mesa, Arizona, Stany Zjednoczone, 85202
        • Banner Children's at Desert
      • Phoenix, Arizona, Stany Zjednoczone, 85016
        • Phoenix Childrens Hospital
      • Tucson, Arizona, Stany Zjednoczone, 85719
        • Banner University Medical Center - Tucson
    • Arkansas
      • Little Rock, Arkansas, Stany Zjednoczone, 72202-3591
        • Arkansas Children's Hospital
    • California
      • Downey, California, Stany Zjednoczone, 90242
        • Kaiser Permanente Downey Medical Center
      • Duarte, California, Stany Zjednoczone, 91010
        • City of Hope Comprehensive Cancer Center
      • Loma Linda, California, Stany Zjednoczone, 92354
        • Loma Linda University Medical Center
      • Long Beach, California, Stany Zjednoczone, 90806
        • Miller Children's and Women's Hospital Long Beach
      • Los Angeles, California, Stany Zjednoczone, 90048
        • Cedars-Sinai Medical Center
      • Los Angeles, California, Stany Zjednoczone, 90027
        • Children's Hospital Los Angeles
      • Madera, California, Stany Zjednoczone, 93636
        • Valley Children's Hospital
      • Oakland, California, Stany Zjednoczone, 94611
        • Kaiser Permanente-Oakland
      • Orange, California, Stany Zjednoczone, 92868
        • Children's Hospital of Orange County
      • Sacramento, California, Stany Zjednoczone, 95816
        • Sutter Medical Center Sacramento
      • Sacramento, California, Stany Zjednoczone, 95817
        • University of California Davis Comprehensive Cancer Center
      • San Diego, California, Stany Zjednoczone, 92123
        • Rady Children's Hospital - San Diego
      • San Diego, California, Stany Zjednoczone, 92134
        • Naval Medical Center -San Diego
      • Santa Barbara, California, Stany Zjednoczone, 93102
        • Santa Barbara Cottage Hospital
      • Torrance, California, Stany Zjednoczone, 90502
        • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
    • Colorado
      • Aurora, Colorado, Stany Zjednoczone, 80045
        • Children's Hospital Colorado
      • Denver, Colorado, Stany Zjednoczone, 80218
        • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
    • Connecticut
      • Hartford, Connecticut, Stany Zjednoczone, 06106
        • Connecticut Children's Medical Center
      • New Haven, Connecticut, Stany Zjednoczone, 06520
        • Yale University
    • Delaware
      • Wilmington, Delaware, Stany Zjednoczone, 19803
        • Alfred I duPont Hospital for Children
    • District of Columbia
      • Washington D.C., District of Columbia, Stany Zjednoczone, 20010
        • Children's National Medical Center
      • Washington D.C., District of Columbia, Stany Zjednoczone, 20007
        • MedStar Georgetown University Hospital
    • Florida
      • Fort Lauderdale, Florida, Stany Zjednoczone, 33316
        • Broward Health Medical Center
      • Fort Myers, Florida, Stany Zjednoczone, 33908
        • Golisano Children's Hospital of Southwest Florida
      • Gainesville, Florida, Stany Zjednoczone, 32610
        • UF Health Cancer Institute - Gainesville
      • Hollywood, Florida, Stany Zjednoczone, 33021
        • Memorial Regional Hospital/Joe DiMaggio Children's Hospital
      • Jacksonville, Florida, Stany Zjednoczone, 32207
        • Nemours Children's Clinic-Jacksonville
      • Miami, Florida, Stany Zjednoczone, 33155
        • Nicklaus Children's Hospital
      • Miami, Florida, Stany Zjednoczone, 33136
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
      • Miami, Florida, Stany Zjednoczone, 33176
        • Miami Cancer Institute
      • Orlando, Florida, Stany Zjednoczone, 32827
        • Nemours Children's Hospital
      • Orlando, Florida, Stany Zjednoczone, 32803
        • AdventHealth Orlando
      • Orlando, Florida, Stany Zjednoczone, 32806
        • Arnold Palmer Hospital for Children
      • Pensacola, Florida, Stany Zjednoczone, 32504
        • Nemours Children's Clinic - Pensacola
      • St. Petersburg, Florida, Stany Zjednoczone, 33701
        • Johns Hopkins All Children's Hospital
      • Tampa, Florida, Stany Zjednoczone, 33606
        • Tampa General Hospital
      • Tampa, Florida, Stany Zjednoczone, 33607
        • Saint Joseph's Hospital/Children's Hospital-Tampa
      • West Palm Beach, Florida, Stany Zjednoczone, 33407
        • Saint Mary's Medical Center
    • Georgia
      • Atlanta, Georgia, Stany Zjednoczone, 30329
        • Children's Healthcare of Atlanta - Arthur M Blank Hospital
      • Augusta, Georgia, Stany Zjednoczone, 30912
        • Augusta University Medical Center
      • Savannah, Georgia, Stany Zjednoczone, 31404
        • Memorial Health University Medical Center
    • Hawaii
      • Honolulu, Hawaii, Stany Zjednoczone, 96826
        • Kapiolani Medical Center for Women and Children
    • Idaho
      • Boise, Idaho, Stany Zjednoczone, 83712
        • Saint Luke's Cancer Institute - Boise
    • Illinois
      • Chicago, Illinois, Stany Zjednoczone, 60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, Stany Zjednoczone, 60612
        • University of Illinois
      • Chicago, Illinois, Stany Zjednoczone, 60611
        • Lurie Children's Hospital-Chicago
      • Maywood, Illinois, Stany Zjednoczone, 60153
        • Loyola University Medical Center
      • Oak Lawn, Illinois, Stany Zjednoczone, 60453
        • Advocate Children's Hospital-Oak Lawn
      • Park Ridge, Illinois, Stany Zjednoczone, 60068
        • Advocate Children's Hospital-Park Ridge
      • Peoria, Illinois, Stany Zjednoczone, 61637
        • OSF Children's Hospital of Illinois
      • Springfield, Illinois, Stany Zjednoczone, 62702
        • Southern Illinois University School of Medicine
    • Indiana
      • Indianapolis, Indiana, Stany Zjednoczone, 46202
        • Riley Hospital for Children
      • Indianapolis, Indiana, Stany Zjednoczone, 46260
        • Ascension Saint Vincent Indianapolis Hospital
    • Iowa
      • Des Moines, Iowa, Stany Zjednoczone, 50309
        • Blank Children's Hospital
      • Iowa City, Iowa, Stany Zjednoczone, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
    • Kentucky
      • Lexington, Kentucky, Stany Zjednoczone, 40536
        • University of Kentucky/Markey Cancer Center
      • Louisville, Kentucky, Stany Zjednoczone, 40202
        • Norton Children's Hospital
    • Louisiana
      • New Orleans, Louisiana, Stany Zjednoczone, 70121
        • Ochsner Medical Center Jefferson
      • New Orleans, Louisiana, Stany Zjednoczone, 70118
        • Children's Hospital New Orleans
    • Maine
      • Bangor, Maine, Stany Zjednoczone, 04401
        • Eastern Maine Medical Center
    • Maryland
      • Baltimore, Maryland, Stany Zjednoczone, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Baltimore, Maryland, Stany Zjednoczone, 21215
        • Sinai Hospital of Baltimore
      • Baltimore, Maryland, Stany Zjednoczone, 21201
        • University of Maryland/Greenebaum Cancer Center
      • Bethesda, Maryland, Stany Zjednoczone, 20889-5600
        • Walter Reed National Military Medical Center
    • Massachusetts
      • Boston, Massachusetts, Stany Zjednoczone, 02111
        • Tufts Children's Hospital
      • Springfield, Massachusetts, Stany Zjednoczone, 01199
        • Baystate Medical Center
      • Worcester, Massachusetts, Stany Zjednoczone, 01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Ann Arbor, Michigan, Stany Zjednoczone, 48109
        • C S Mott Children's Hospital
      • Detroit, Michigan, Stany Zjednoczone, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit, Michigan, Stany Zjednoczone, 48236
        • Henry Ford Health Saint John Hospital
      • East Lansing, Michigan, Stany Zjednoczone, 48823
        • Michigan State University
      • Flint, Michigan, Stany Zjednoczone, 48503
        • Hurley Medical Center
      • Grand Rapids, Michigan, Stany Zjednoczone, 49503
        • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
      • Kalamazoo, Michigan, Stany Zjednoczone, 49007
        • Bronson Methodist Hospital
      • Royal Oak, Michigan, Stany Zjednoczone, 48073
        • Corewell Health Children's
    • Minnesota
      • Minneapolis, Minnesota, Stany Zjednoczone, 55404
        • Children's Hospitals and Clinics of Minnesota - Minneapolis
      • Minneapolis, Minnesota, Stany Zjednoczone, 55455
        • University of Minnesota/Masonic Cancer Center
      • Rochester, Minnesota, Stany Zjednoczone, 55905
        • Mayo Clinic in Rochester
    • Mississippi
      • Jackson, Mississippi, Stany Zjednoczone, 39216
        • University of Mississippi Medical Center
    • Missouri
      • Columbia, Missouri, Stany Zjednoczone, 65212
        • University of Missouri Children's Hospital
      • Kansas City, Missouri, Stany Zjednoczone, 64108
        • Children's Mercy Hospitals and Clinics
      • St Louis, Missouri, Stany Zjednoczone, 63110
        • Washington University School of Medicine
      • St Louis, Missouri, Stany Zjednoczone, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, Stany Zjednoczone, 63104
        • Cardinal Glennon Children's Medical Center
    • Nebraska
      • Omaha, Nebraska, Stany Zjednoczone, 68198
        • University of Nebraska Medical Center
      • Omaha, Nebraska, Stany Zjednoczone, 68114
        • Children's Hospital and Medical Center of Omaha
    • Nevada
      • Las Vegas, Nevada, Stany Zjednoczone, 89144
        • Summerlin Hospital Medical Center
      • Las Vegas, Nevada, Stany Zjednoczone, 89109
        • Sunrise Hospital and Medical Center
      • Las Vegas, Nevada, Stany Zjednoczone, 89135
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
      • Las Vegas, Nevada, Stany Zjednoczone, 89102
        • University Medical Center of Southern Nevada
    • New Hampshire
      • Lebanon, New Hampshire, Stany Zjednoczone, 03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
    • New Jersey
      • Hackensack, New Jersey, Stany Zjednoczone, 07601
        • Hackensack University Medical Center
      • Morristown, New Jersey, Stany Zjednoczone, 07960
        • Morristown Medical Center
      • New Brunswick, New Jersey, Stany Zjednoczone, 08901
        • Saint Peter's University Hospital
      • New Brunswick, New Jersey, Stany Zjednoczone, 08903
        • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital
      • Newark, New Jersey, Stany Zjednoczone, 07112
        • Newark Beth Israel Medical Center
      • Paterson, New Jersey, Stany Zjednoczone, 07503
        • Saint Joseph's Regional Medical Center
    • New Mexico
      • Albuquerque, New Mexico, Stany Zjednoczone, 87106
        • University of New Mexico Cancer Center
    • New York
      • Albany, New York, Stany Zjednoczone, 12208
        • Albany Medical Center
      • Buffalo, New York, Stany Zjednoczone, 14263
        • Roswell Park Cancer Institute
      • Mineola, New York, Stany Zjednoczone, 11501
        • NYU Langone Hospital - Long Island
      • New Hyde Park, New York, Stany Zjednoczone, 11040
        • The Steven and Alexandra Cohen Children's Medical Center of New York
      • New York, New York, Stany Zjednoczone, 10065
        • Memorial Sloan Kettering Cancer Center
      • New York, New York, Stany Zjednoczone, 10029
        • Mount Sinai Hospital
      • New York, New York, Stany Zjednoczone, 10032
        • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
      • New York, New York, Stany Zjednoczone, 10065
        • NYP/Weill Cornell Medical Center
      • New York, New York, Stany Zjednoczone, 10016
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
      • Rochester, New York, Stany Zjednoczone, 14642
        • University of Rochester
      • Stony Brook, New York, Stany Zjednoczone, 11794
        • Stony Brook University Medical Center
      • Syracuse, New York, Stany Zjednoczone, 13210
        • State University of New York Upstate Medical University
      • The Bronx, New York, Stany Zjednoczone, 10467
        • Montefiore Medical Center - Moses Campus
    • North Carolina
      • Asheville, North Carolina, Stany Zjednoczone, 28801
        • Mission Hospital
      • Chapel Hill, North Carolina, Stany Zjednoczone, 27599
        • UNC Lineberger Comprehensive Cancer Center
      • Charlotte, North Carolina, Stany Zjednoczone, 28203
        • Carolinas Medical Center/Levine Cancer Institute
      • Charlotte, North Carolina, Stany Zjednoczone, 28204
        • Novant Health Presbyterian Medical Center
      • Durham, North Carolina, Stany Zjednoczone, 27710
        • Duke University Medical Center
      • Greenville, North Carolina, Stany Zjednoczone, 27834
        • East Carolina University
      • Winston-Salem, North Carolina, Stany Zjednoczone, 27157
        • Wake Forest University Health Sciences
    • North Dakota
      • Fargo, North Dakota, Stany Zjednoczone, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Akron, Ohio, Stany Zjednoczone, 44308
        • Children's Hospital Medical Center of Akron
      • Cincinnati, Ohio, Stany Zjednoczone, 45229
        • Cincinnati Children's Hospital Medical Center
      • Cleveland, Ohio, Stany Zjednoczone, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Stany Zjednoczone, 44106
        • Rainbow Babies and Childrens Hospital
      • Columbus, Ohio, Stany Zjednoczone, 43205
        • Nationwide Children's Hospital
      • Dayton, Ohio, Stany Zjednoczone, 45404
        • Dayton Children's Hospital
      • Toledo, Ohio, Stany Zjednoczone, 43606
        • ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
    • Oklahoma
      • Oklahoma City, Oklahoma, Stany Zjednoczone, 73104
        • University of Oklahoma Health Sciences Center
    • Oregon
      • Portland, Oregon, Stany Zjednoczone, 97239
        • Oregon Health and Science University
      • Portland, Oregon, Stany Zjednoczone, 97227
        • Legacy Emanuel Children's Hospital
    • Pennsylvania
      • Allentown, Pennsylvania, Stany Zjednoczone, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Bethlehem, Pennsylvania, Stany Zjednoczone, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Danville, Pennsylvania, Stany Zjednoczone, 17822
        • Geisinger Medical Center
      • Hershey, Pennsylvania, Stany Zjednoczone, 17033
        • Penn State Children's Hospital
      • Philadelphia, Pennsylvania, Stany Zjednoczone, 19104
        • Children's Hospital of Philadelphia
      • Philadelphia, Pennsylvania, Stany Zjednoczone, 19134
        • Saint Christopher's Hospital for Children
      • Pittsburgh, Pennsylvania, Stany Zjednoczone, 15224
        • Children's Hospital of Pittsburgh of UPMC
    • Rhode Island
      • Providence, Rhode Island, Stany Zjednoczone, 02903
        • Rhode Island Hospital
    • South Carolina
      • Charleston, South Carolina, Stany Zjednoczone, 29425
        • Medical University of South Carolina
      • Columbia, South Carolina, Stany Zjednoczone, 29203
        • Prisma Health Richland Hospital
      • Greenville, South Carolina, Stany Zjednoczone, 29605
        • BI-LO Charities Children's Cancer Center
    • South Dakota
      • Sioux Falls, South Dakota, Stany Zjednoczone, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
    • Tennessee
      • Chattanooga, Tennessee, Stany Zjednoczone, 37403
        • T C Thompson Children's Hospital
      • Knoxville, Tennessee, Stany Zjednoczone, 37916
        • East Tennessee Childrens Hospital
      • Nashville, Tennessee, Stany Zjednoczone, 37232
        • Vanderbilt University/Ingram Cancer Center
      • Nashville, Tennessee, Stany Zjednoczone, 37203
        • The Children's Hospital at TriStar Centennial
    • Texas
      • Austin, Texas, Stany Zjednoczone, 78723
        • Dell Children's Medical Center of Central Texas
      • Corpus Christi, Texas, Stany Zjednoczone, 78411
        • Driscoll Children's Hospital
      • Dallas, Texas, Stany Zjednoczone, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Dallas, Texas, Stany Zjednoczone, 75230
        • Medical City Dallas Hospital
      • El Paso, Texas, Stany Zjednoczone, 79905
        • El Paso Children's Hospital
      • Fort Worth, Texas, Stany Zjednoczone, 76104
        • Cook Children's Medical Center
      • Houston, Texas, Stany Zjednoczone, 77030
        • UT MD Anderson Cancer Center
      • Houston, Texas, Stany Zjednoczone, 77030
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
      • Lubbock, Texas, Stany Zjednoczone, 79410
        • Covenant Children's Hospital
      • Lubbock, Texas, Stany Zjednoczone, 79415
        • UMC Cancer Center / UMC Health System
      • San Antonio, Texas, Stany Zjednoczone, 78229
        • University of Texas Health Science Center at San Antonio
      • San Antonio, Texas, Stany Zjednoczone, 78207
        • Children's Hospital of San Antonio
      • San Antonio, Texas, Stany Zjednoczone, 78229
        • Methodist Children's Hospital of South Texas
      • Temple, Texas, Stany Zjednoczone, 76508
        • Scott and White Memorial Hospital
    • Utah
      • Salt Lake City, Utah, Stany Zjednoczone, 84113
        • Primary Children's Hospital
    • Vermont
      • Burlington, Vermont, Stany Zjednoczone, 05405
        • University of Vermont and State Agricultural College
    • Virginia
      • Charlottesville, Virginia, Stany Zjednoczone, 22908
        • University of Virginia Cancer Center
      • Falls Church, Virginia, Stany Zjednoczone, 22042
        • Inova Fairfax Hospital
      • Norfolk, Virginia, Stany Zjednoczone, 23507
        • Children's Hospital of The King's Daughters
      • Richmond, Virginia, Stany Zjednoczone, 23298
        • VCU Massey Comprehensive Cancer Center
    • Washington
      • Seattle, Washington, Stany Zjednoczone, 98105
        • Seattle Children's Hospital
      • Spokane, Washington, Stany Zjednoczone, 99204
        • Providence Sacred Heart Medical Center and Children's Hospital
      • Tacoma, Washington, Stany Zjednoczone, 98405
        • Mary Bridge Children's Hospital and Health Center
      • Tacoma, Washington, Stany Zjednoczone, 98431
        • Madigan Army Medical Center
    • West Virginia
      • Charleston, West Virginia, Stany Zjednoczone, 25304
        • Vandalia Health/CAMC Institute for Academic Medicine
      • Morgantown, West Virginia, Stany Zjednoczone, 26506
        • West Virginia University Healthcare
    • Wisconsin
      • Green Bay, Wisconsin, Stany Zjednoczone, 54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • Madison, Wisconsin, Stany Zjednoczone, 53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Marshfield, Wisconsin, Stany Zjednoczone, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, Stany Zjednoczone, 53226
        • Children's Hospital of Wisconsin

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

2 lata do 22 lata (Dziecko, Dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • Patients with newly diagnosed, pathologically confirmed cHL meeting one of the following Ann Arbor stages are eligible:

    • Stage IIB with bulk

    • Stage IIIB

    • Stage IVA

    • Stage IVB

      • If study eligibility by staging is uncertain, consultation with Imaging and Radiation Oncology Core (IROC) Rhode Island (RI) may be obtained prior to study enrollment
  • Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows (performed within 14 days prior to enrollment):

    • 2 to < 6 years: male 0.8 mg/dL, female 0.8 mg/dL
    • 6 to < 10 years: male 1 mg/dL, female 1 mg/dL
    • 10 to < 13 years: male 1.2 mg/dL, female 1.2 mg/dL
    • 13 to < 16 years: male 1.5 mg/dL, female 1.4 mg/dL
    • >= 16 years: male 1.7 mg/dL, female 1.4 mg/dL
  • Total bilirubin =< 1.5 x upper limit of normal (ULN) for age (performed within 14 days prior to enrollment)

  • Serum glutamic oxaloacetic transaminase (SGOT) (aspartate transaminase [AST]) or serum glutamate pyruvate transaminase (SGPT) (alanine transaminase [ALT]) < 2.5 x upper limit of normal (ULN) for age (performed within 14 days prior to enrollment)

  • Shortening fraction of >= 27% by echocardiogram, or ejection fraction of >= 50% by radionuclide angiogram

  • Forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) > 60% by pulmonary function test (PFT), unless due to large mediastinal mass from Hodgkin lymphoma (HL)

  • For children who are unable to cooperate for PFTs, the criteria are: no evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry reading of > 92% on room air

  • All patients and/or their parents or legal guardians must sign a written informed consent

  • All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Exclusion Criteria:

  • Patients with nodular lymphocyte-predominant HL
  • Patients with an immunodeficiency that existed prior to diagnosis, such as primary immunodeficiency syndromes, organ transplant recipients and children on current systemic immunosuppressive agents are not eligible
  • Patients who are pregnant; (since fetal toxicities and teratogenic effects have been noted for several of the study drugs, a negative pregnancy test is required for female patients of childbearing potential)
  • Lactating females who plan to breastfeed
  • Sexually active patients of reproductive potential who have not agreed to use an effective contraceptive method for the duration of their study participation and for 30 days after the last dose of chemotherapy
  • Patients known to be positive for human immunodeficiency virus (HIV) are not eligible
  • Patients who have received any previous chemotherapy or radiation therapy are not eligible
  • Patients who received systemic corticosteroids within 28 days of enrollment on this protocol, except as specified, are not eligible

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Aktywny komparator: Arm I (ABVE-PC)

Patients receive doxorubicin hydrochloride IV over on days 1-2, bleomycin sulfate IV or SC on days 1 and 8, vincristine sulfate IV on days 1 and 8, etoposide IV on days 1-3, prednisone orally PO BID or methylprednisolone IV on days 1-7, and cyclophosphamide IV on days 1 and 2. Treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity.

Correlative studies

Ancillary studies

Inne nazwy:
  • Ocena jakości życia

Given IV

Inne nazwy:
  • Cytoksan
  • CTX
  • (-)-cyklofosfamid
  • 2H-1,3,2-Oksazafosforyna, 2-[bis(2-chloroetylo)amino]tetrahydro-, 2-tlenek, monohydrat
  • Karloksan
  • Cyklofosfamida
  • Cyklofosfamid
  • Cykloksal
  • Clafen
  • Klafen
  • Monohydrat CP
  • Ogniwo CYCLO
  • Cykloblastyna
  • Cyklofosfam
  • Monohydrat cyklofosfamidu
  • Cyklofosfan
  • Cyklostyna
  • Cytofosfan
  • Fosfaseron
  • Genoksal
  • Genuxal
  • Ledoksyna
  • Mitoksan
  • Neosar
  • Revimmune
  • Syklofosfamid
  • WR-138719
  • Asta B 518
  • B-518
  • B518
  • WR 138719
  • WR138719
  • Frindovyx

Given IV

Inne nazwy:
  • Adriamycyna
  • 5,12-Naftacenodion, 10-[(3-amino-2,3,6-trideoksy-alfa-L-lyxo-hexopiranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroksy -8-(hydroksyacetylo)-1-metoksy-, chlorowodorek, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Chlorowodorek adriamycyny
  • Adriamycyna PFS
  • Adriamycyna RDF
  • ADRIAMYCYNA, CHLOROWODOREK
  • Adriblastina
  • Adriblastyna
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doksolem
  • Chlorowodorek doksorubicyny
  • Doksorubina
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroksydaunorubicyna
  • Rubex
  • FI106

Given PO

Inne nazwy:
  • Deltazon
  • Orason
  • .delta.1-kortyzon
  • 1,2-Dehydrokortyzon
  • Adaśon
  • Kortancyl
  • Dakortyna
  • DeCortin
  • Dekortyzyl
  • Decorton
  • Delta 1-kortyzon
  • Delta Dome
  • Deltakorten
  • Deltakortyzon
  • Deltadehydrokortyzon
  • Deltisona
  • Deltra
  • Ekonozon
  • Lisacort
  • Meprosona-F
  • Metakortandracyna
  • Meticorten
  • Ofizolona
  • Panafcort
  • Panasol-S
  • Parakort
  • Perrigo Prednizon
  • PRZED
  • Predicor
  • Predicorten
  • Prednicen-M
  • Prednicort
  • Prednidyb
  • Prednilonga
  • Predniment
  • Prednizon Intensol
  • Prednizon
  • Predniton
  • Promifen
  • Rayo
  • Serwisowany
  • SK-Prednizon

Given IV

Inne nazwy:
  • Oncovin
  • Kyocristine
  • Siarczan Leurokrystyny
  • Leurokrystyna, siarczan
  • Vincasar
  • Vincosid
  • Vincrex
  • Winkrystyna, siarczan

Ancillary studies

Given IV

Inne nazwy:
  • Demetylo Epipodofilotoksyna Glukozyd etylidyny
  • EPEG
  • Ostatnie
  • Toposar
  • Vepesid
  • WP 16
  • VP 16-213
  • VP-16
  • VP-16-213
  • VP16
  • VP 16213
  • VP-16213
  • VP16213

Correlative studies

Given IV or SC

Inne nazwy:
  • Bleocin
  • Blenoksan
  • Blanoxan
  • BleMomycine
  • Bleokomórka
  • Bleo-S
  • Bleolem
  • Sulfa bleomycyny
  • Siarczan bleomycyny
  • Bleomycini Sulfas
  • Bleksan
  • Olej Bleo

Given IV

Inne nazwy:
  • Medrol
  • Wyacort
  • Adlone
  • Caberdelta M
  • DepMedalone
  • Depo Moderin
  • Depo-Nisolon
  • Duralone
  • Emmetipi
  • Esameton
  • Firmacort
  • Medlone 21
  • Średnia
  • Medrol Veriderm
  • Medron
  • Mega-Gwiazda
  • Meprolon
  • Metyloprednizolon
  • Rozpuszczalny metylobetazon
  • Metrokort
  • Metyppresol
  • Metysolon
  • Predni-M-Tablin
  • Prednilen
  • Radiem
  • Sieropresol
  • Solpredon
  • Summicort
  • Urbason
  • Veriderm Medrol
Eksperymentalny: ARM II (Bv-AVEPC)

Patients receive brentuximab vedotin IV on day 1. Patients also receive doxorubicin hydrochloride, etoposide, prednisone or methylprednisolone, and cyclophosphamide as in Arm I and vincristine sulfate IV on day 8. Treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity.

Correlative studies

Ancillary studies

Inne nazwy:
  • Ocena jakości życia

Given IV

Inne nazwy:
  • Cytoksan
  • CTX
  • (-)-cyklofosfamid
  • 2H-1,3,2-Oksazafosforyna, 2-[bis(2-chloroetylo)amino]tetrahydro-, 2-tlenek, monohydrat
  • Karloksan
  • Cyklofosfamida
  • Cyklofosfamid
  • Cykloksal
  • Clafen
  • Klafen
  • Monohydrat CP
  • Ogniwo CYCLO
  • Cykloblastyna
  • Cyklofosfam
  • Monohydrat cyklofosfamidu
  • Cyklofosfan
  • Cyklostyna
  • Cytofosfan
  • Fosfaseron
  • Genoksal
  • Genuxal
  • Ledoksyna
  • Mitoksan
  • Neosar
  • Revimmune
  • Syklofosfamid
  • WR-138719
  • Asta B 518
  • B-518
  • B518
  • WR 138719
  • WR138719
  • Frindovyx

Given IV

Inne nazwy:
  • Adriamycyna
  • 5,12-Naftacenodion, 10-[(3-amino-2,3,6-trideoksy-alfa-L-lyxo-hexopiranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroksy -8-(hydroksyacetylo)-1-metoksy-, chlorowodorek, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Chlorowodorek adriamycyny
  • Adriamycyna PFS
  • Adriamycyna RDF
  • ADRIAMYCYNA, CHLOROWODOREK
  • Adriblastina
  • Adriblastyna
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doksolem
  • Chlorowodorek doksorubicyny
  • Doksorubina
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroksydaunorubicyna
  • Rubex
  • FI106

Given PO

Inne nazwy:
  • Deltazon
  • Orason
  • .delta.1-kortyzon
  • 1,2-Dehydrokortyzon
  • Adaśon
  • Kortancyl
  • Dakortyna
  • DeCortin
  • Dekortyzyl
  • Decorton
  • Delta 1-kortyzon
  • Delta Dome
  • Deltakorten
  • Deltakortyzon
  • Deltadehydrokortyzon
  • Deltisona
  • Deltra
  • Ekonozon
  • Lisacort
  • Meprosona-F
  • Metakortandracyna
  • Meticorten
  • Ofizolona
  • Panafcort
  • Panasol-S
  • Parakort
  • Perrigo Prednizon
  • PRZED
  • Predicor
  • Predicorten
  • Prednicen-M
  • Prednicort
  • Prednidyb
  • Prednilonga
  • Predniment
  • Prednizon Intensol
  • Prednizon
  • Predniton
  • Promifen
  • Rayo
  • Serwisowany
  • SK-Prednizon

Given IV

Inne nazwy:
  • Oncovin
  • Kyocristine
  • Siarczan Leurokrystyny
  • Leurokrystyna, siarczan
  • Vincasar
  • Vincosid
  • Vincrex
  • Winkrystyna, siarczan

Ancillary studies

Given IV

Inne nazwy:
  • Adcetris
  • SGN-35
  • cAC10-vcMMAE
  • ADC SGN-35
  • Koniugat przeciwciało-lek anty-CD30 SGN-35
  • Przeciwciało monoklonalne anty-CD30-MMAE SGN-35
  • Przeciwciało monoklonalne anty-CD30-Monometyloaurystatyna E SGN-35
  • SGN35
  • SGN 35

Given IV

Inne nazwy:
  • Demetylo Epipodofilotoksyna Glukozyd etylidyny
  • EPEG
  • Ostatnie
  • Toposar
  • Vepesid
  • WP 16
  • VP 16-213
  • VP-16
  • VP-16-213
  • VP16
  • VP 16213
  • VP-16213
  • VP16213

Correlative studies

Given IV

Inne nazwy:
  • Medrol
  • Wyacort
  • Adlone
  • Caberdelta M
  • DepMedalone
  • Depo Moderin
  • Depo-Nisolon
  • Duralone
  • Emmetipi
  • Esameton
  • Firmacort
  • Medlone 21
  • Średnia
  • Medrol Veriderm
  • Medron
  • Mega-Gwiazda
  • Meprolon
  • Metyloprednizolon
  • Rozpuszczalny metylobetazon
  • Metrokort
  • Metyppresol
  • Metysolon
  • Predni-M-Tablin
  • Prednilen
  • Radiem
  • Sieropresol
  • Solpredon
  • Summicort
  • Urbason
  • Veriderm Medrol

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Event Free Survival (EFS), Where Events Include Disease Progression or Relapse, Second Malignancy, or Death
Ramy czasowe: Up to 48 months after the last enrollment

Primary analysis will be based 1-sided log rank test comparison of EFS curves between the 2 randomized arms per intention-to-treat principle. Progression is defined as an ≥50% increase of in the product of the perpendicular diameters of any of the involved nodes or nodal masses or focal organ lesions in sites that were persistently PET positive; or recurrent PET positive lesions (Deauville 4, 5) in sites that had previously been PET negative regardless of change of size, as was the development of new PET avid measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Relapse is defined in patients who achieved a prior CR but subsequently has an increase of ≥50% of the PPD in prior nodal or extranodal sites in a recurrently PET positive lesion(s), or the development of new measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Second malignancy is defined based on report of a cancer that is not considered to be classic Hodgkin Lymphoma.

Up to 48 months after the last enrollment

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Percentages of Patients With Early Response Defined as no Slow Responding Lesions (SRL) and no Progressive Disease (PD) at Any Disease Sites Determined by Positron Emission Tomography (PET) Per Deauville Criteria Through Central Review
Ramy czasowe: After 42 days of chemotherapy

The percentages of patients (with available PET scan) with no SRL and no PD will be compared between the two randomized arms to see if brentuximab vedotin in the chemotherapy backbone of doxorubicin hydrochloride, vincristine sulfate, etoposide, prednisone and cyclophosphamide (Bv-AVEPC) arm has a higher rate of early response compared to doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide (ABVE-PC) arm. Two-sample Z test of proportions at 1-sided alpha level of 0.05 will be used for these comparisons.

After 42 days of chemotherapy
Percentages of Patients Experiencing Grade 3+ Peripheral Neuropathy Assessed by Modified Balis Scale
Ramy czasowe: From the enrollment of the patient to the time of analysis or the last follow-up; an average of 3.6 years.

The percentages of patients experiencing grade 3+ peripheral neuropathy assessed by the treating clinician using the modified Balis scale. The "Modified Balis scale of Pediatric Neuropathy" allows clinicians to assign a score for sensory or motor neuropathy symptoms separately. Scores range from 1 to 4 with 1 being the least symptomatic state and 4 indicating a severe debility. The percentages of patients (with a score >/=3) will be compared between the 2 arms by two-sample Z test at 1-sided alpha level of 0.05.

From the enrollment of the patient to the time of analysis or the last follow-up; an average of 3.6 years.

Inne miary wyników

Miara wyniku
Opis środka
Ramy czasowe
Childhood International Prognostic Score (CHIPS) Score
Ramy czasowe: Baseline

CHIPS will be computed for all patients and summarized by descriptive statistics. Will examine the association between CHIPS and early response by cross-tabulations and Chi-square tests within each arm separately, as well as logistic regression model where early response is the outcome variable and CHIPS the predictor variable combining the 2 arms with adjustment for randomized chemotherapy.

Baseline
Dose of Radiation Received by Normal Tissues Following Chemotherapy on Either Study Arm
Ramy czasowe: Up to 48 months

Descriptive statistics will be used to summarize RT doses received by normal tissues on this study. Two-sample t-test will be used to compare the doses received on this study to those on prior studies.

Up to 48 months
Efficacy of Involved Site Radiotherapy (ISRT) by Analyzing the Event-free Survival of Patients Treated With Response-adapted ISRT and by Evaluating Patterns of Relapse Following ISRT
Ramy czasowe: Up to 3 years

EFS for patients on each arm as well as those receiving ISRT or those with slow early response (SER) on each arm will be estimated. One-sample log rank test will be used to compare the observed EFS to the assumed baseline of 82% at 3 years to see if the observed EFS is significantly lower than the projection in these subsets.

Up to 3 years
Risk of Relapse Among RRL Subjects That Have at Least One Lesion That is Deauville 3 at PET 2
Ramy czasowe: Up to 48 months after the last enrollment

The risk of relapse for cases that are RRL, but have Deauville 3 lesions, will be compared to those that are classified as complete metabolic response at PET2 with solely Deauville 1 or 2 lesions with K-sample test.

Up to 48 months after the last enrollment
Pharmacokinetic (PK) Analyses
Ramy czasowe: Pre-dose and end of infusion on day 1, days 2, 3, 8, and 15 of cycle 4 and pre-dose on day 1 and day 22 of cycle 5 (each cycle = 21 days)

PK concentration time profile will be evaluated.

Pre-dose and end of infusion on day 1, days 2, 3, 8, and 15 of cycle 4 and pre-dose on day 1 and day 22 of cycle 5 (each cycle = 21 days)

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Śledczy

  • Główny śledczy: Sharon M Castellino, Children's Oncology Group

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Publikacje ogólne

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

19 marca 2015

Zakończenie podstawowe (Rzeczywisty)

31 grudnia 2021

Ukończenie studiów (Szacowany)

14 października 2027

Daty rejestracji na studia

Pierwszy przesłany

16 czerwca 2014

Pierwszy przesłany, który spełnia kryteria kontroli jakości

16 czerwca 2014

Pierwszy wysłany (Szacowany)

18 czerwca 2014

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

13 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

10 listopada 2026

Ostatnia weryfikacja

1 czerwca 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • NCI-2014-01223
  • U10CA180886 (Grant/umowa NIH USA)
  • NCI-2014-01223 (Identyfikator rejestru: CTRP (Clinical Trial Reporting Program))
  • s15-00950
  • AHOD1331 (Inny identyfikator: CTEP)
  • AHOD1331 (Inny identyfikator: Children's Oncology Group)

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .